Compare AMTX & LNSR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMTX | LNSR |
|---|---|---|
| Founded | 2005 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Medical Electronics |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 109.8M | 106.6M |
| IPO Year | 2023 | 2005 |
| Metric | AMTX | LNSR |
|---|---|---|
| Price | $1.91 | $8.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $12.00 | $10.00 |
| AVG Volume (30 Days) | ★ 891.4K | 154.5K |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.98 | N/A |
| EPS | N/A | ★ 0.61 |
| Revenue | ★ $77,194,000.00 | $58,435,000.00 |
| Revenue This Year | $49.77 | $10.06 |
| Revenue Next Year | $57.87 | $41.48 |
| P/E Ratio | ★ N/A | $15.13 |
| Revenue Growth | ★ 174.60 | 9.24 |
| 52 Week Low | $1.30 | $4.95 |
| 52 Week High | $3.80 | $12.94 |
| Indicator | AMTX | LNSR |
|---|---|---|
| Relative Strength Index (RSI) | 57.13 | 78.80 |
| Support Level | $1.41 | $5.25 |
| Resistance Level | $2.77 | $12.13 |
| Average True Range (ATR) | 0.12 | 0.46 |
| MACD | 0.03 | 0.26 |
| Stochastic Oscillator | 63.33 | 96.25 |
Aemetis Inc is an renewable fuel and biochemicals company focused on the production of renewable fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products through the conversion of first-generation ethanol and biodiesel plants into biorefineries. In addition to low carbon renewable fuel ethanol, the Keyes Plant produces Wet Distillers Grains, Distillers Corn Oil, and Condensed Distillers Solubles, all of which are sold to local dairies and feedlots as animal feed. The operations include California Ethanol, California Dairy Renewable Natural Gas and India Biodiesel. It operates in the reportable geographic segments of North America and India.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, simplified procedure planning, efficient design, and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia (excluding South Korea), South Korea, and Other.